Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LATITUDE: Losmapimod in Acute Coronary Syndrome
NCT02145468Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 34
01
Overview
A Phase 3 trial of losmapimod in acute coronary syndrome (ACS), sponsored by GSK. Started Jun 2014; status: completed.
02
Drugs
losmapimod
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02145468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02145468.